Abstract:In budding yeast, Sir2 is a NAD+-dependent histone deacetylase that plays a role in chromatin silencing, longevity and genomic stability. In mammals, sirtuins exist as a family of 7 members (SIRT1-7) that deacetylate histones and many nonhistone proteins. Currently, all sirtuins have been knocked out by gene targeting, and the mutant mice suffer various abnormalities in cell growth, apoptosis, neurological behavior, adaptation to calorie restriction, organ metabolism and function, and/or premature aging, highlighting critical roles of sirtuins in these biological processes. Of note, mice carrying mutations of SIRT1, SIRT2 or SIRT3 also developed cancers, predominantly in the mammary glands and the liver that are accompanied by genomic instability and/or abnormal energy metabolism. Our further analysis revealed distinct role of these siruins in maintaining genome integrity. SIRT1 mutant cells displayed altered histone modification, impaired DNA damage response, and reduced ability to repair DNA damage [1]; SIRT3 mutant cells had increased stress-induced superoxide levels and genomic instability [2]; and SIRT2 loss primarily affects mitotic functions. We found that SIRT2 plays a role in maintaining normal mitosis progression through modulating expression levels of several mitotic regulators, including Aurora-A and -B. Loss of SIRT2, consequently, causes centrosome amplification, aneuploidy, and mitotic catastrophe. SIRT2-deficient mice initially develop normally, however, suffer mammary tumors and hepatocellular carcinoma (HCC) when they become old. These data highlight how accurate maintenance of genomic integrity is critical for the suppression of tumorigenesis. Finally, we found that human breast cancer and HCC exhibit reduced levels of SIRT1-3. These results implicate SIRT1-3 as tumor suppressors in these organs. References: 1. Wang RH, Sengupta K, Li C. et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. 2008; 14: 312-323. 2. Kim HS, Patel K, Muldoon-Jacobs K. et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010; 17: 41-52. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr SY11-01. doi:10.1158/1538-7445.AM2011-SY11-01

Supplemental Figures 1-5 from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents

SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Knockout Mouse Models For Sirtuins: Genome Integrity, Metabolism, And Cancer

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Supplemental Methods and Figure S1 from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer

Supplementary Figure 4 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves As a Prognostic Factor in Colorectal Cancer

SIRT5 Inhibits Peroxisomal ACOX1 to Prevent Oxidative Damage and is Downregulated in Liver Cancer.

SIRT2 inhibition protects against cardiac hypertrophy and heart failure

Supplementary Figure 3 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Regulation of SIRT2 Levels for Human Non-Small Cell Lung Cancer Therapy.

Sirt6 Protects Cardiomyocytes Against Doxorubicin-Induced Cardiotoxicity by Inhibiting P53/Fas-dependent Cell Death and Augmenting Endogenous Antioxidant Defense Mechanisms

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Supplementary Figure 5 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

SIRT3 is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism During Stress.

Data from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Supplemental Figures 1-5 from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents

SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Knockout Mouse Models For Sirtuins: Genome Integrity, Metabolism, And Cancer

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Supplemental Methods and Figure S1 from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer

Supplementary Figure 4 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves As a Prognostic Factor in Colorectal Cancer

SIRT5 Inhibits Peroxisomal ACOX1 to Prevent Oxidative Damage and is Downregulated in Liver Cancer.

SIRT2 inhibition protects against cardiac hypertrophy and heart failure

Supplementary Figure 3 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Regulation of SIRT2 Levels for Human Non-Small Cell Lung Cancer Therapy.

Sirt6 Protects Cardiomyocytes Against Doxorubicin-Induced Cardiotoxicity by Inhibiting P53/Fas-dependent Cell Death and Augmenting Endogenous Antioxidant Defense Mechanisms

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1&lt;b&gt;α&lt;/b&gt;–Dependent Glycolysis

Supplementary Figure 5 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

SIRT3 is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism During Stress.

Data from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis